Significant associations seen for functional iron deficiency with coronary heart disease, cardiovascular mortality, all-cause mortality
Emerging data demonstrate that iron is an important regulator of FGF23.
Blood urea nitrogen (BUN) in NDD-CKD represents nitrogenous uremic toxin accumulation that could be involved in anemia of CKD.
The factors that may account for any excess stroke risk among ESA users remain unclear.
The FDA noted that the application could not be approved in its present form and had requested an additional clinical study be conducted.
Researchers sought to determine whether patients with anemia had an increased risk of ischemic stroke and poststroke mortality.
Lead in municipal drinking water, even at levels allowed by the EPA, are associated with lower hemoglobin levels in patients with advanced chronic kidney disease, a study found.
In a small study, approximately a third of kidney transplant recipients had anemia and half had persistent secondary hyperparathyroidism.
Treating iron deficiency in patients with chronic kidney disease may be necessary even in the absence of anemia, according to investigators.
The first generic version of Feraheme (ferumoxytol injection) has been made available by Sandoz.